Though current guidelines recommend antiplatelet therapy for patients with cryptogenic stroke, new research is examining the effect of anticoagulation therapy on patient outcomes. Researcher Hooman Kamel,...
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug...
Systsje Anne Bergstra, PhD, from Leiden University Medical Center answers our questions about her study that compared DMARD treatment regimens among patients with rheumatoid arthritis who failed initial...
